跳至主要内容
临床试验/NCT02593357
NCT02593357已完成不适用

Assessment of a Peripheral Endothelial Dysfunction in COPD (Chronic Obstructive Pulmonary Disease)

Hopital Foch2 个研究点 分布在 1 个国家目标入组 137 人开始时间: 2012年12月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Hopital Foch
入组人数
137
试验地点
2
主要终点
measure of reactive hyperemia-peripheral artery tone index

研究概览

简要总结

The aim of the study is to assess the peripheral endothelial function in adult COPD (chronic obstructive pulmonary disease) patients and the relationship between the peripheral endothelial function and the pulmonary function.

详细描述

The primary criteria is the peripheral endothelial function that will be assessed by the measure of flow-mediated dilation (reactive hyperemia-peripheral artery tone index). The pulmonary function will be assessed by the measures of the FEV1 (forced expiratory volume in one second), the forced vital capacity (FVC) and the expiratory flow between 25% and 75% (FEF25-75%). The relationship between these parameters of the pulmonary function and the peripheral endothelial function will be analyzed. In addition, a relationship between peripheral endothelial function and the severity of COPD (classification according to GOLD (Global Initiative for Chronic Obstructive Lung Disease) 2010 and GOLD 2011 and the COPD assessment test, the cardiovascular risk factors (SCORE INdex) and the smoker status will be also assessed.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •COPD : FEV1/FVC < 70%
  • •Smokers or ex-smokers ( ≥ 10 pack-years)
  • •No COPD exacerbation in the last three months
  • •No history of asthma and no respiratory allergy

排除标准

  • •Pregnant or nursing women
  • •Treatment with pulmonary vasodilators
  • •Patients with a significant acute disease. A significant disease is defined as a disease which, in the opinion of the investigator, may influence the results of the trial.

研究组 & 干预措施

COPD patients

Experimental

measure of endothelial function with EndoPAT® in COPD patients

干预措施: COPD patients (Device)

结局指标

主要结局

measure of reactive hyperemia-peripheral artery tone index

时间窗: Day 1

measure of reactive hyperemia-peripheral artery tone index

次要结局

  • measure of forced vital capacity(day 1)
  • measure of expiratory flow between 25% and 75% (FEF25-75%).(day 1)
  • measure of Forced expiratory flow in one second(day 1)

研究者

发起方
Hopital Foch
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验